vs
ANAPTYSBIO, INC（ANAB）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是ANAPTYSBIO, INC的1.7倍（$188.3M vs $108.2M），BRC Group Holdings, Inc.净利率更高（47.9% vs 45.8%，领先2.1%），ANAPTYSBIO, INC同比增速更快（151.1% vs -21.9%），过去两年ANAPTYSBIO, INC的营收复合增速更高（288.3% vs -15.4%）
AnaptysBio是一家处于临床阶段的生物技术企业，专注于开发适用于炎症疾病、肿瘤免疫及罕见病领域的抗体类免疫疗法，主要面向美国市场，推进创新候选药物管线研发以满足未被满足的临床需求。
ANAB vs RILY — 直观对比
营收规模更大
RILY
是对方的1.7倍
$108.2M
营收增速更快
ANAB
高出172.9%
-21.9%
净利率更高
RILY
高出2.1%
45.8%
两年增速更快
ANAB
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $108.2M | $188.3M |
| 净利润 | $49.6M | $90.3M |
| 毛利率 | — | 79.5% |
| 营业利润率 | 61.8% | 32.3% |
| 净利率 | 45.8% | 47.9% |
| 营收同比 | 151.1% | -21.9% |
| 净利润同比 | 327.8% | 1710.8% |
| 每股收益（稀释后） | $1.64 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANABRILY
| Q4 25 | $108.2M | $188.3M | ||
| Q3 25 | $76.3M | $215.3M | ||
| Q2 25 | $22.3M | $188.2M | ||
| Q1 25 | $27.8M | $197.2M | ||
| Q4 24 | $43.1M | $241.0M | ||
| Q3 24 | $30.0M | $225.5M | ||
| Q2 24 | $11.0M | $256.0M | ||
| Q1 24 | $7.2M | $263.4M |
净利润ANABRILY
| Q4 25 | $49.6M | $90.3M | ||
| Q3 25 | $15.1M | $91.1M | ||
| Q2 25 | $-38.6M | $139.5M | ||
| Q1 25 | $-39.3M | $-10.0M | ||
| Q4 24 | $-21.8M | $-5.6M | ||
| Q3 24 | $-32.9M | $-284.4M | ||
| Q2 24 | $-46.7M | $-433.6M | ||
| Q1 24 | $-43.9M | $-49.2M |
毛利率ANABRILY
| Q4 25 | — | 79.5% | ||
| Q3 25 | — | 83.7% | ||
| Q2 25 | — | 81.3% | ||
| Q1 25 | — | 81.4% | ||
| Q4 24 | — | 79.8% | ||
| Q3 24 | — | 82.1% | ||
| Q2 24 | — | 84.5% | ||
| Q1 24 | — | 85.3% |
营业利润率ANABRILY
| Q4 25 | 61.8% | 32.3% | ||
| Q3 25 | 45.5% | 30.4% | ||
| Q2 25 | -117.5% | 5.7% | ||
| Q1 25 | -99.2% | -31.2% | ||
| Q4 24 | -22.4% | -69.2% | ||
| Q3 24 | -75.8% | -36.4% | ||
| Q2 24 | -367.5% | -90.8% | ||
| Q1 24 | -587.8% | -6.1% |
净利率ANABRILY
| Q4 25 | 45.8% | 47.9% | ||
| Q3 25 | 19.8% | 42.3% | ||
| Q2 25 | -173.5% | 74.1% | ||
| Q1 25 | -141.6% | -5.1% | ||
| Q4 24 | -50.5% | -2.3% | ||
| Q3 24 | -109.4% | -126.1% | ||
| Q2 24 | -425.3% | -169.4% | ||
| Q1 24 | -612.0% | -18.7% |
每股收益（稀释后）ANABRILY
| Q4 25 | $1.64 | $2.78 | ||
| Q3 25 | $0.52 | $2.91 | ||
| Q2 25 | $-1.34 | $4.50 | ||
| Q1 25 | $-1.28 | $-0.39 | ||
| Q4 24 | $-0.63 | $-0.01 | ||
| Q3 24 | $-1.14 | $-9.39 | ||
| Q2 24 | $-1.71 | $-14.35 | ||
| Q1 24 | $-1.64 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.2M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $37.2M | $-171.5M |
| 总资产 | $364.4M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ANABRILY
| Q4 25 | $238.2M | $226.6M | ||
| Q3 25 | $109.8M | $184.2M | ||
| Q2 25 | $44.3M | $267.4M | ||
| Q1 25 | $98.6M | $138.3M | ||
| Q4 24 | $123.1M | $146.9M | ||
| Q3 24 | $191.6M | $159.2M | ||
| Q2 24 | $71.8M | $236.9M | ||
| Q1 24 | $53.7M | $190.7M |
总债务ANABRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ANABRILY
| Q4 25 | $37.2M | $-171.5M | ||
| Q3 25 | $-29.4M | $-260.5M | ||
| Q2 25 | $-44.7M | $-351.7M | ||
| Q1 25 | $34.0M | $-496.8M | ||
| Q4 24 | $70.9M | $-488.2M | ||
| Q3 24 | $84.4M | $-497.6M | ||
| Q2 24 | $9.9M | $-218.3M | ||
| Q1 24 | $47.8M | $228.4M |
总资产ANABRILY
| Q4 25 | $364.4M | $1.7B | ||
| Q3 25 | $353.1M | $1.7B | ||
| Q2 25 | $335.3M | $1.5B | ||
| Q1 25 | $422.1M | $1.5B | ||
| Q4 24 | $483.8M | $1.8B | ||
| Q3 24 | $493.4M | $2.2B | ||
| Q2 24 | $427.4M | $3.2B | ||
| Q1 24 | $405.8M | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.0M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $98.0M | — |
| 自由现金流率自由现金流/营收 | 90.5% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.98× | 0.29× |
| 过去12个月自由现金流最近4个季度 | $19.6M | — |
8季度趋势，按日历期对齐
经营现金流ANABRILY
| Q4 25 | $98.0M | $26.2M | ||
| Q3 25 | $-27.4M | $-60.6M | ||
| Q2 25 | $-40.2M | $-25.6M | ||
| Q1 25 | $-10.7M | $184.0K | ||
| Q4 24 | $-66.7M | $-2.7M | ||
| Q3 24 | $-10.1M | $19.5M | ||
| Q2 24 | $-21.3M | $111.5M | ||
| Q1 24 | $-37.3M | $135.4M |
自由现金流ANABRILY
| Q4 25 | $98.0M | — | ||
| Q3 25 | $-27.4M | — | ||
| Q2 25 | $-40.3M | — | ||
| Q1 25 | $-10.7M | — | ||
| Q4 24 | $-66.9M | — | ||
| Q3 24 | $-10.1M | — | ||
| Q2 24 | $-21.4M | — | ||
| Q1 24 | $-37.3M | — |
自由现金流率ANABRILY
| Q4 25 | 90.5% | — | ||
| Q3 25 | -35.9% | — | ||
| Q2 25 | -180.9% | — | ||
| Q1 25 | -38.7% | — | ||
| Q4 24 | -155.3% | — | ||
| Q3 24 | -33.7% | — | ||
| Q2 24 | -194.6% | — | ||
| Q1 24 | -519.3% | — |
资本支出强度ANABRILY
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.4% | — |
现金转化率ANABRILY
| Q4 25 | 1.98× | 0.29× | ||
| Q3 25 | -1.81× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANAB
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
